Live Breaking News & Updates on Thrombus

Stay informed with the latest breaking news from Thrombus on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Thrombus and stay connected to the pulse of your community

The Plaque Hypothesis: Focus on Vulnerable Lesions to Cut Events

A new strategy is needed targeting unstable plaque in the whole of the coronary arteries, rather than just obstructive lesions, to reduce major adverse cardiac events, a new review suggests.

Boston , Massachusetts , United-states , Boston-university , Peter-libby , Williame-boden , Boston-university-school-of-medicine , Boston-university-school , Medscape-cardiology , Ischemia-hypothesis , Cv

Tiny, Menacing Microclots May Explain Long COVID's Symptoms

Some long COVID researchers have suspected smaller, less obvious blood clots may be causing many of the puzzling symptoms reported by patients who have lasting effects of the virus.

Germany , New-york , United-states , South-africa , United-kingdom , Stellenbosch , Western-cape , Massachusetts , Douglas-kell , Lumbrokinase-serrapeptase , Etheresia-resia-pretorius , Michael-vanelzakker

Highly Selective Bailout GPI May Benefit in STEMI-PCI Subgroup

Bailout GP IIb/IIIa inhibition ups bleeding risk without preventing ischemic events in STEMI-PCI patients also having thrombectomy, a registry study suggests. One subgroup may have had a net benefit.

China , United-states , Tianjin , Chinese , American , American-heart-association , Academic-research-consortium , National-natural-science-foundation-of-china , Pfizer , Astrazeneca , Chinese-society-of-cardiology

New Biomarker Flags VTE Risk in COVID-19 Patients

New findings point to a biomarker even more sensitive than D-dimer in detecting risk for VTE in hospitalized patients with COVID-19.

United-states , Ann-arbor , Michigan , Berlin , Germany , American , Salim-hayek , Geoffrey-barnes , Walden-biosciences , Jochen-reiser , University-of-michigan-frankel-cardiovascular-center-clinics , National-institute-of-diabetes

FDA Limits Use of J&J COVID Vaccine Over Blood Clot Risk

'We recognize that the Janssen COVID-19 vaccine still has a role in the current pandemic response in the United States and across the global community,' the FDA's Peter Marks said.

United-states , Peter-marks , Janssen-johnson , Johnson , Pfizer , Advisory-committee-on-immunization-practices , Biologics-evaluation , Immunization-practices , Certain-individuals , Updated-interim-recommendations , Advisory-committee , Covid-19-vaccine